Masaki, Naohiko <br/><br/>
Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C.  [electronic resource] 

 -  Digestive diseases and sciences  Oct 2002 
 - 2163-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0163-2116 
<br/><br/><label>Standard No.: </label>10.1023/a:1020114722763  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Interferon-beta--adverse effects<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>RNA, Viral--blood<br/>Th1 Cells--drug effects<br/>Th2 Cells--drug effects<br/>Treatment Outcome